Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 171023
Gene Symbol: ASXL1
ASXL1 		0.500 Biomarker phenotype CTD_human Dynamics of clonal evolution in myelodysplastic syndromes. 27992414 2017
Entrez Id: 2623
Gene Symbol: GATA1
GATA1 		0.500 Biomarker phenotype CTD_human Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro. 28963909 2017
Entrez Id: 171023
Gene Symbol: ASXL1
ASXL1 		0.500 Biomarker phenotype MGD Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice. 24255920 2014
Entrez Id: 2623
Gene Symbol: GATA1
GATA1 		0.500 Biomarker phenotype MGD Role of GATA-1 in proliferation and differentiation of definitive erythroid and megakaryocytic cells in vivo. 9657742 1998
Entrez Id: 10735
Gene Symbol: STAG2
STAG2 		0.300 Biomarker phenotype CTD_human Dynamics of clonal evolution in myelodysplastic syndromes. 27992414 2017
Entrez Id: 7097
Gene Symbol: TLR2
TLR2 		0.300 Biomarker phenotype CTD_human Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro. 28963909 2017
Entrez Id: 8233
Gene Symbol: ZRSR2
ZRSR2 		0.300 Biomarker phenotype CTD_human Dynamics of clonal evolution in myelodysplastic syndromes. 27992414 2017
Entrez Id: 861
Gene Symbol: RUNX1
RUNX1 		0.300 Biomarker phenotype CTD_human Dynamics of clonal evolution in myelodysplastic syndromes. 27992414 2017
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.300 Biomarker phenotype CTD_human Dynamics of clonal evolution in myelodysplastic syndromes. 27992414 2017
Entrez Id: 54790
Gene Symbol: TET2
TET2 		0.300 Biomarker phenotype CTD_human Dynamics of clonal evolution in myelodysplastic syndromes. 27992414 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53 		0.300 Biomarker phenotype CTD_human Dynamics of clonal evolution in myelodysplastic syndromes. 27992414 2017
Entrez Id: 2624
Gene Symbol: GATA2
GATA2 		0.300 Biomarker phenotype CTD_human Dynamics of clonal evolution in myelodysplastic syndromes. 27992414 2017
Entrez Id: 3065
Gene Symbol: HDAC1
HDAC1 		0.300 Biomarker phenotype CTD_human Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro. 28963909 2017
Entrez Id: 54809
Gene Symbol: SAMD9
SAMD9 		0.300 Biomarker phenotype CTD_human SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7. 27182967 2016
Entrez Id: 648
Gene Symbol: BMI1
BMI1 		0.300 Biomarker phenotype CTD_human BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression. 24571310 2014
Entrez Id: 2624
Gene Symbol: GATA2
GATA2 		0.300 Biomarker phenotype CTD_human Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. 21892162 2011
Entrez Id: 7307
Gene Symbol: U2AF1
U2AF1 		0.300 Biomarker phenotype CTD_human Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. 22158538 2011
Entrez Id: 2624
Gene Symbol: GATA2
GATA2 		0.300 Biomarker phenotype CTD_human Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). 21892158 2011
Entrez Id: 2146
Gene Symbol: EZH2
EZH2 		0.300 Biomarker phenotype CTD_human Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. 20601954 2010
Entrez Id: 1612
Gene Symbol: DAPK1
DAPK1 		0.300 Biomarker phenotype CTD_human Epigenetic changes in therapy-related MDS/AML. 19874806 2010
Entrez Id: 54790
Gene Symbol: TET2
TET2 		0.300 Biomarker phenotype CTD_human Acquired mutations in TET2 are common in myelodysplastic syndromes. 19483684 2009
Entrez Id: 546
Gene Symbol: ATRX
ATRX 		0.300 Biomarker phenotype CTD_human Assessment of ATRX expression in patients with myelodysplastic syndromes treated with decitabine. 19157545 2009
Entrez Id: 23236
Gene Symbol: PLCB1
PLCB1 		0.300 Biomarker phenotype CTD_human Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. 19805378 2009
Entrez Id: 8877
Gene Symbol: SPHK1
SPHK1 		0.300 Biomarker phenotype CTD_human Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells. 18283525 2008
Entrez Id: 8788
Gene Symbol: DLK1
DLK1 		0.300 Biomarker phenotype CTD_human Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells. 18575777 2008